← Back to Clinical Trials
Recruiting NCT06081231
Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China
Trial Parameters
Condition Type 1 Diabetes Mellitus
Sponsor Third Affiliated Hospital, Sun Yat-Sen University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 500
Sex ALL
Min Age 3 Years
Max Age 75 Years
Start Date 2019-01-01
Completion 2026-01-01
Interventions
open-source APS;
Brief Summary
This real-world observational study aims to reveal the current status of the open-source artificial pancreas system (APS) use among people with T1DM in China and assess the glycemic efficacy and potential related factors of the open-source APS.
Eligibility Criteria
Inclusion Criteria: 1. diagnosed T1DM. 2. Currently use open-source APS for at least 3 months. 3. Willing and able to provide informed consent (or be a parent or other legally authorized representative) and to provide the data. 4. reside in China. Exclusion Criteria: None
Related Trials
NCT04096794
Chinese Alliance for Type 1 Diabetes Multi-center Collaborative Research
View Trial →
NCT06081231
Open-Source Artificial Pancreas System Use Among People With Type 1 Diabetes Mellitus in China
View Trial →
NCT07409701
Gamification Intervertion in Children With Type 1 Diabetes
View Trial →